Esoteric Testing Market Size and Share Analysis by Test Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing), Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA Sequencing, Flow Cytometry), End User (Independent & Reference Laboratories, Hospital-Based Laboratories) - Global Industry Demand Forecast to 2030
The global esoteric testing market generated revenue of USD 23,373 million in 2022, which is expected to witness a CAGR of 11.70% during 2022–2030, reaching USD 56,643 million by 2030.
Empty Capsules Market Size and Share Analysis by Type (Gelatin Capsules, Non-Gelatin Capsules), Functionality (Immediate-Release Capsules, Sustained-Release Capsules, Delayed-Release Capsules), Application (Antibiotic Drugs, Dietary Supplements, Antacid and Antiflatulent, Cardiovascular Therapy Drugs), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, Research Laboratories) - Global Industry Demand Forecast to 2030
The global empty capsules market generated revenue of USD 2,818 million in 2022, which is expected to witness a CAGR of 7.10% during 2022–2030, to reach USD 4,879 million by 2030.
The immunotherapy drugs market size stood at USD 121,746 million in 2022, and it is expected to grow at a CAGR of 7.10% during 2023–2030, to reach USD 210,752 million by 2030.
Gene Therapy Market Size and Growth Analysis by Type (In vivo, Ex vivo), Vector Type (Viral, Non-Viral), Application (Oncology, Rare Diseases, Neurology, Ophthalmology, Hematology, Infectious Diseases, Cardiology), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes and Research Centers) - Global Industry Demand Forecast to 2030
The global gene therapy market size stood at USD 7,420 million in 2022, and it is expected to touch USD 29,440 million by 2030, advancing at a CAGR of 18.80% between 2022 and 2030.
The global animal healthcare market was valued at USD 40.2 billion in 2022, and the market size is predicted to reach USD 84.9 billion by 2030, advancing at a CAGR of 9.8% during 2022–2030.
Generic Drugs Market Analysis by Type (Simple, Super, Biosimilars), Application (Neurological Diseases, Cardiological Diseases, Metabolic Diseases, Infectious Diseases, Orthopedic Diseases, Genitourinary/Hormonal Diseases, Respiratory Diseases), Route of Administration (Oral, Injection, Cutaneous, Mucosal, Inhalation), Distribution Channel (Indirect, Direct) – Global Industry Growth and Demand Forecast to 2030
The global generic drugs market estimated to generate revenue of $404.3 billion in 2022, and it is expected to advance at a compound annual growth rate of 7.20% during 2022–2030, to reach $705.1 billion by 2030.
Age-Related Macular Degeneration Market Size and Share Analysis by Drug Type (Lucentis, Eylea, Beovu), Disease Type (Dry AMD, Wet AMD), Age Group (Less Than 60, Between 60 to 80, More Than 80), Gender (Male, Female), Stages (Early AMD, Intermediate AMD, Advanced AMD, No AMD), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) - Global Industry Revenue Estimation and Demand Forecast to 2030
The global age-related macular degeneration market stood at $10,234 million in 2021, and it is projected to reach $18,500 million by 2030, growing at a significant CAGR of 6.8% between 2021 and 2030.
Mineral Supplements Market Size and Share Analysis by Product Type (Calcium, Magnesium, Iron, Potassium, Zinc, Chromium, Selenium), Formulation (Tablets, Capsules, Soft Gels, Powders, Gummies, Liquids), Application (Food and Beverage, Pharmaceutical), End-User (Adult Women, Adult Men, Senior Citizen) - Global Industry Demand forecast to 2030
The global mineral supplements market size stood at $13.19 billion in 2021, which is expected to reach $21.0 billion by 2030, advancing at a CAGR of 5.3% during 2021–2030.
Osteoporosis Drugs Market Share Analysis by Type (Bisphosphonates, Selective Estrogen Receptor Modulators, Parathyroid Hormone Therapy, RANK Ligand Inhibitors), Route of Administration (Oral, Injectable), Application (Primary Osteoporosis, Secondary Osteoporosis) - Global Industry Revenue Estimation and Demand Forecast to 2030
The global osteoporosis drugs market was valued at $14,576.3 million in 2021, and the market size is predicted to reach $22,947.0 million by 2030, advancing at a CAGR of 5.2% during 2021–2030.
Next-Generation Antibody Therapeutics Market Outlook by Therapeutic Area (Oncology, Autoimmune/Inflammatory), Technology (Antibody–Drug Conjugates, Bispecific Antibodies, Fc-Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, Biosimilar Antibody Products) - Global Industry Revenue Estimation to 2030
The global next-generation antibody therapeutics market size stood at $5,619.7 million in 2021, which is expected to reach $15,308.6 million by 2030, advancing at a CAGR of 11.8% during 2021–2030.
Biopharmaceutical Market Share Analysis Report by Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines), Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases) - Global Industry Demand Forecast to 2030
The biopharmaceuticals market size stood at $389.3 billion in 2021, and it is expected to grow at a CAGR of 7.1% during 2021–2030, to reach $720.8 billion by 2030.
Clinical Trials Outsourcing Market Outlook by Phase (Phase-I, Phase-2, Phase-3, Phase-4), End User (Small & Mid-Size Companies, Large Companies), Application (Cancer, Cardiovascular Diseases, Infectious Diseases, Nervous System Disorder, Musculoskeletal Diseases, Gastroenterology Disease) - Global Industry Revenue Estimation and Demand Forecast to 2030
The global clinical trials outsourcing market was valued at $40,428.4 million in 2021, and it will grow at a CAGR of 7.2% during the forecast period, to reach $75,573.4 million by 2030.
The global microbiome therapeutics market size in 2021 was $314.4 million, and it is expected to advance at a CAGR of 23.1% during the forecast period, to reach $2,036.4 million by 2030.
The global BPH treatment market size was $11,892.8 million in 2021, and it is projected to reach $18,837.7 million in 2030, with a growth rate of 5.2% during 2021–2030.
Anticoagulants Market Size and Share Analysis Report by Drug Type (Direct Oral Anticoagulants, Warfarin, Other Vitamin K, Heparins & Low Molecular Weight Heparin), Disease Indication (Heart Attack, Stroke, Deep Vein Thrombosis / Pulmonary Embolism, Mechanical Heart Valves), Route of Administration (Oral, Injection), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Demand Forecast to 2030
The global anticoagulants market size in 2021 was $21,736.2 million, and it is expected to advance at a CAGR of 7.8% during the forecast period, to reach $42,893.4 million by 2030.
In-Silico Drug Discovery Market Report: By Product (Software, Software-as-a-Service, Consultancy-as-a-Service), Workflow (Discovery, Pre-Clinical Tests, Clinical Tests), Technology (Artificial Intelligence), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes) – Global Industry Outlook and Demand Forecast to 2030
The global in-silico drug discovery market was valued at $2,331.8 million in 2021, and the market size is predicted to reach $5,682.3 million by 2030, advancing at a CAGR of 10.4% during 2021–2030.
The radioligand therapy market size stood at $7,785.6 million in 2021, and rising at a compound annual growth rate of 5.9% during 2021–2030, it will reach $13,073.9 million by 2030.
The global anti-vascular endothelial growth factor therapeutics market revenue stood at $12,178.0 million in 2021, and it is expected to advance at a CAGR of 1.4% during 2021–2030, to reach $13,812.6 million by 2030.
Human Growth Hormone Market Report: By Product Type (Short-Acting Growth Hormones, Long-Acting Growth Hormones), Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Industry Revenue Estimation and Demand Forecast to 2030
The global human growth hormone market size was $4,399.4 million in 2021, and it is expected to grow at a CAGR of 14.2% during 2021–2030.
Pharmacovigilance Market Report: By Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV), Service Provider (In-House, Third Parties), Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), Process Flow (Case Data Management, Signal Detection, Risk Management System), Therapeutic Area (Oncology, Neurology, Cardiology, Pulmonology), End Use (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers) – Global Industry Trends and Growth Prospects, 2022-2030
The global pharmacovigilance market was estimated to generate $6,724.2 million in 2021, and it will grow with a CAGR of 9.5% during the forecast period, to further expand to $15,259.8 million by 2030.
The global biologics CDMO market size was estimated at $13,173.7 million in 2021. This number is expected to increase to $31,839.7 million by 2030, at a CAGR of 10.3% during 2021–2030.
Active Pharmaceutical Ingredient Market Research Report: By Type of Manufacturer (Captive, Merchant), Type (Generic APIs, Innovative APIs), Type of Synthesis (Biotech, Synthetic), Type of Drug (Prescription Drugs, OTC Drugs), Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Pain Management, Respiratory Diseases), Distribution Channel (Offline, Online) - Global Industry Revenue Estimation to 2030
The global active pharmaceutical ingredient (API) market generated $184,311.2 million revenue in 2020, and it is expected to grow at a CAGR of 6.9% during the forecast period (2021–2030).
Asia-Pacific Gene Therapy Market Research Report: Type (In Vivo, Ex Vivo), Vector Type (Adenovirus, Non-Viral, Herpes, Simplex Virus), Application (Carcinoma, Nasopharyngeal, Cancer, Acute Lymphoblastic Leukemia, Critical Limb Ischemia, Melanoma), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes and Research Centers) - Industry Analysis and Demand Forecast to 2030
The Asia-Pacific (APAC) gene therapy market valued $349.1 million in 2020, which is projected to progress at a CAGR of 36.8% during the forecast period (2021–2030).
Psoriasis Drugs Market Research Report: By Type (Biologic Drugs, Small-Molecule Systemic Drugs, Topical Therapies), Mechanism of Action (Tumor Necrosis Factor-Alpha Inhibitors, Phosphodiesterase Type 4 Inhibitors, Interleukin Inhibitors), Route of Administration (Oral, Parenteral, Topical) - Global Industry Analysis and Demand Forecast to 2030
The global psoriasis drugs market was valued at $14,504.0 million in 2020, which is projected to progress at a CAGR of 14.0% during the forecast period (2021–2030).
Dermatology Drugs Market Research Report: By Treatment (Topical Corticosteroids, Retinoids, Biologics, Calcineurin Inhibitors, Antihistamines, Hormone Therapy), Drug (Humira, Remicade, Otezla, Stelara, Enbrel, Cosentyx, Neoral, Taltz, Cubicin, Canesten, Zyvox, Dupixent, Protopic, Valtrex, Eucrisa), Prescription Mode (Prescription Drugs, Over-the-Counter Drugs), Therapy Area (Psoriasis, Atopic Dermatitis, Acne, Rosacea, Skin Cancer, Scar), Distribution Channel (Direct, Wholesale/Retail), End User (Hospitals, Clinics, Cosmetic centers, At-home) - Global Industry Analysis and Growth Forecast to 2030
The global dermatology drugs market was valued at $25,228.2 million in 2019, which is expected to progress at a CAGR of 8.8% during the forecast period (2020–2030).
Biosimilars Market By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Technology (mAb, rDNA, Bioassays, Nuclear Magnetic Resonance, Electrophoresis), Indication (Oncology, Rheumatology, Blood-Related Disorders, Auto-Immune Diseases, Chronic Diseases, Infectious Diseases, Growth Hormone Deficiency), Route of Administration (Intravenous, Subcutaneous, Intranasal), Geographical Outlook – Trends Analysis and Growth Forecast to 2024
The biosimilars market size was $6.0 billion in 2018, and it is expected to advance at a CAGR of 29.6% during 2019–2024.
Wet Age-Related Macular Degeneration (AMD) Market by Product (Lucentis, Eylea, Avastin), by Distribution Channel (Direct, Indirect), by Age Group (Above 80 Years, 60–80 Years, 40–59 Years), by Route of Administration (Intravitreal, Intravenous), by End User (Hospitals & Clinics, Research & Academic Institutes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Russia, Sweden, Norway, Belgium, Switzerland, Austria, China, Japan, India, South Korea, Malaysia, Thailand, Australia, Singapore, Brazil, Mexico, Argentina, Colombia, Israel, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2024
The global wet age-related macular degeneration (AMD) market is expected to generate revenue worth $10.4 billion in 2024, registering a CAGR of 7.1% during 2019–2024. The increasing prevalence of AMD, lack of availability of specific treatment, and surge in geriatric population are the major factors influencing the market growth.
Human Insulin (HI) Market by Product (HI Drugs [HI Analogs, HI Biologics], HI Delivery Devices [Syringes, Pens, Pen Needles, Pumps]), by Application (Type II Diabetes, Type I Diabetes, Gestational Diabetes & Prediabetes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023
The global human insulin market valued $42.9 billion in 2017 and is projected to register a CAGR of 8.8% during the period 2018-2023, on account of the rising number of diabetic patients, growing geriatric population, technological advancements in insulin delivery devices, and increasing population exposure to risk factors leading to diabetes.
In the coming years, the medical marijuana market would observe considerable prosperity, due to the increasing incidence of chronic diseases, number of countries allowing the use of the substance for medication purposes, awareness of patients as well as doctors about the benefits of cannabis, and investments for research and development (R&D).
Acne vulgaris develops on the face and upper trunk and most often affects adolescents. The causes of the acne include excess oil production, clogging of air follicles by oil and dead skin cells, and excess activity of androgens. The clinical presentation of acne vulgaris ranges from a mild comedonal form to severe inflammatory cystic acne of the face, chest, and back.
Growing aging population, rising prevalence of BPH disorders, technological advancements in BPH procedures and rising awareness about BPH disorders and the treatments available are some of the factors increasing the number of BPH treatment procedures in the U.S. However, the adoption of BPH procedures in the U.S has been facing certain challenges such as side-effects associated with BPH treatment procedures and unfavourable healthcare reforms in the U.S., which is likely to impede its growth during the forecast period. Moreo
Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs becomes stiff and dense over time. The scar tissue formation is known as fibrosis. As the fibrosis progresses and tissue become darker, lungs can't properly move oxygen into the bloodstream, which result in oxygen deficiency in brain and other organs.
Benign Prostatic Hyperplasia (BPH) Procedures by Type (Green Light Lasers, Holmium Lasers, Thulium Lasers, TURP, TUIP, TUMT, TUNA, Rezum, HIFU & Water Induced Therapies, UroLift), by End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers), by Geography (Germany, U.K., France, Italy, Spain, U.S., Canada, Australia, Japan, South Korea) - Global Procedures, Developments, Growth and Forecast, 2013-2023
Benign Prostatic Hyperplasia (BPH) refers to an enlarged prostate gland. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. As the prostate gets bigger, it may squeeze or partly block the urethra, causing problems while urinating. BPH is common in aging men, and about half of all men between the ages of 51 and 60 suffer from BPH. It has been observed that up to 90% of men above the age of 80 years have BPH. The treatment methods for BPH include medications, transurethral r
Hemophilia is a genetic disorder characterized by excessive bleeding and delayed blood clotting. There are two types of hemophilia, hemophilia A (also known as classic hemophilia) and hemophilia B. According to the Centers for Disease Control and Prevention, the incidence of hemophilia stands at, one out of every 5,000 male births and as many as 20,000 males in the U.S., living with either of the two types of hemophilia, presently. The prevalence of hemophilia A is around four times high as compared to the prevalence of h
Age-related macular degeneration is a disorder that causes loss of vision in a person due to macula damage; macula is that part of an eye, which helps a person to see, it is made up of millions of light-sensing cells which provide sharp and central vision. Age-related macular degeneration progresses slowly in an individual and can eventually lead to blindness. The most common symptom of Age-related macular degeneration is blurry vision.
Herpes is an infection caused by a virus known as, herpes simplex virus. It is estimated, that around 3.7 billion people under the age of 50 years are suffering with the herpes simplex virus infection, globally. The disease is categorized into two types: HSV1 and HSV2. HSV1, also known as oral herpes can lead to sores on the mouth and around the lips, HSV2 causes genital herpes. A person can get infected with HSV1 by sharing lip balm, kissing and eating from the same utensils. HSV2 spreads through sexual contact with a pe
Amyotrophic lateral sclerosis is a disease that causes progression in neurodegeneration in brain and spinal cord. In Amyotrophic lateral sclerosis, the muscle does not get adequate nourishment due to which it becomes atrophic. The disease occurs in the lateral region, an area in which spinal cord reflexes are found majorly. Therefore, the degeneration leads to hardening and scarring of muscles in that region. The progressive degeneration of neurons from brain to the spinal cord and spinal cord to the whole body can ultimatel
Ewing sarcoma is a condition in which formation of cancer or tumor takes place in the bones and soft tissues. It is the second most common type of primary sarcoma found in young adults and children. Ewing sarcoma occurs in ribs, long bones, spine (vertebral column) and pelvis. The prevalence of Ewing sarcoma has increased in the past few years, but the exact cause of the disease is still unknown; some of the risk factors that increase the probability of occurrence of Ewing sarcoma include genetic changes (translocation betwe
Estrogen Receptor-Positive (ER+) breast cancer is the most common type of breast cancer diagnosed and it refers to the cancer cells that have receptors on their surface to bind with estrogen. Breast cancer is said to be estrogen receptor-positive (ER+), if it contains estrogen that receives signals from estrogen to promote cell growth. Breast cancer is a syndrome that affects breast tissues and cells in the breast grow in an uncontrollable manner forming
Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)
Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cancer and other malignancies. Programmed death 1 (PD-1) is found on the surface of cancer cells and it is used by tumor cells to evade the immune system. PD-1 inhibitors
Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Facial Aesthetic Relaxant Drug (Botox, Dysport, and Others), By Skeletal Muscle Relaxant Drug (Baclofen, Methocarbamol, Carisoprodol, Metaxalone, Tizanidine, and Others), and by Neuromuscular Blocking Agent (Non-depolarizing Agents, and Depolarizing Agents)
The global muscle relaxant drugs market is predicted to grow at a CAGR of 5.5% during the forecast period (2015–2020).
The growing geriatric population and increasing demand of innovative and advanced pain relaxing medications around the world are the predominant growth drivers for the global pain management drugs market. Additionally, the increasing number of hospitalization cases; unmet requirements for neuropathic pain management drugs; innovative and advanced applications of
Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Hepatitis A, Hepatitis B, Hepatitis C, and Others), by Hepatitis B Drugs (Baraclude, Viread, Tyzeka, Hepsera, and Others), and By Hepatitis C Drugs (Sovaldi, OLYSIO, Harvoni, Pegasys, PegIntron, Victrelis, and Others)
The hepatitis drugs market is expected to reach $118.5 billion by 2020, registering a CAGR of 29.7% during 2016–2020, globally.
The global anti-obesity drugs market is growing significantly, due to high prevalence of obesity and rich pipeline for anti-obesity drugs. The presence of large patient pool and massive unexplored market in the emerging economies, such as India and China, are creating ample opportunities for the growth of the global anti-obesity drugs market. The advanced research and development
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent
The global contraceptives market is growing significantly due to increasing incidences of unwanted pregnancies, increasing prevalence of sexually transmitted diseases and advances in contraception techniques. In addition, government and non-government organizations are funding and supporting programs to encourage contraception. Large unexplored contraceptives
The global influenza vaccine market is growing significantly due increasing awareness about the pandemic influenza viruses and increasing government involvement for vaccination against influenza viruses.Massive unexplored influenza vaccine marketin the emerging economiesare creating ample opportunities for the global influenza vaccine marketto grow at a significant
The global nuclear medicine/radiopharmaceuticals market is growing significantly due to increasing prevalence of cancer and cardiovascular diseases, and advances in nuclear medicine imaging procedures. High demand of nuclear medicines in emerging economies and potential radiopharmaceuticals in the pipeline create ample opportunities for the nuclear
The increase in research and development funds for drug discovery followed by growing awareness of kidney-related disorders, and diabetes are the major factors driving the expansion of the global diabetic nephropathy market. Globally, many programs are organized by the American Diabetes Association to prevent diabetes, create awareness among vulnerable populations, and
Globally, North America is the largest, while Asia-Pacific is the fastest growing uveitis treatment market. The uveitis treatment market is witnessing significant growth, due to increasing prevalence of uveitis and related complications. The global uveitis treatment market currently has many technologically innovative products in the pipeline, which are expected to improve efficiency
Restless legs syndrome increases at night when the patient is at rest. RLS are common in both, male and female; however the disease has its highest impact on woman who are elderly or in some cases woman with the age 35 to 50 years. Some of the most common symptoms of the restless legs syndrome are continue itching and pain in the legs, and unusual sleep pattern. The restless legs syndrome
Pompe disease is a type of lysergic acid diethylamide (LSD). LSD refers to a group of diseases arising from the increase of specific substrates and is inherited autosomal recessive disorders. Lysergic acid diethylamide is progressive and having uneven age of onset and clinical symptoms. Pompe disease is a hereditary and repeatedly incurable disorder caused by lack of acid
Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very carefully so as to ensure their efficacy and safety.
Opioids are directed to the patients suffering from the acute and chronic non-cancer pain. The opioids have numerous adverse intestinal effects, such as opioid-induced constipation. The opioids also affect the discharge of digestive enzymes that can sometime cause partial gastro paresis. Some of the most familiar symptoms of opioid-induced constipation includes, hard and dry
Diabetic retinopathy refers to an eye disorder that damages or harms the blood vessels of the retina. Diabetic retinopathy can cause permanent blindness. Chronic diabetes is a major root of diabetic retinopathy. High glucose level in the blood can damage blood vessels in the retina. Diabetic retinopathy can also cause diabetic macular edema: a medical condition led to the leakage
One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis. Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market.
Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most
Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser therapies, pharmaceutical drugs and surgical
Asthma is a respiratory condition, where the airways become inflamed and narrow, which can cause a serious and incurable condition if left untreated. Breathlessness, wheezing and coughing are some of the symptoms of asthma and it can be controlled by avoiding triggers and with the help of drug therapy. Environmental triggers may vary from consumer to consumer but it can
Choroidal neovascular are the new blood vessels that grow just below the retina and interrupt the vision. Choroid, which is responsible for oxygen and nutrients supply to the eye, is the area between the retina and the sclera, where the blood vessels grow and cause choroidal neovascularization (CNV). Choroidal neovascularization break the barrier between retina and choroid
Infectious diseases are medical conditions or disorders caused by microorganisms such as bacteria, fungi, viruses and other parasites. Several organisms are present in and on human bodies. Some organisms are normally harmless and even helpful. However, under certain circumstances, some organisms cause diseases. Infectious diseases spread from one person to another.